[ { "id": "US-66123", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/biomarker-testing-advanced-prostate-cancer-best-practices.png", "imageAlt": "Best Practices for Biomarker Testing in Patients with Advanced Prostate Cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/FINAL82322Print.pdf", "size": "707.87 KB", "downloadSize": "707.87 KB" }, "website": {}, "label": "FOR HCPS", "title": "Best practices for biomarker testing in patients with advanced prostate cancer", "description": "Download this guide for actionable best practice tips to address challenges in prostate cancer homologous recombination repair mutation (HRRm) testing, including pre-analytical processing, specimen handling, and tissue sample analysis.", "tags": ["US-66123"], "audience": ["hcp"], "tumorType": ["Prostate"], "topic": ["testing-guidelines","testing-best-practices"], "language": ["english"], "publishedAt": "03-01-2025", "speciality":["Pathologist"], "surveyTopic": ["Testing Solutions"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Sample Collection", "Sample Processing", "Testing & Interpretation"] }, { "id": "US-78526", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/genetic-counseling-alternative-service-models-webinar.jpg", "imageAlt": "Best Practices for Utilizing Alternative Service Models for Genetic Counseling", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_6yx4jm96", "duration": "38:03 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_6yx4jm96/flavor/1_1cq69msh", "downloadSize": "1 GB", "fileName": "CORPORATEAZNSGCVideoProgram.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Best practices for utilizing alternative service models for genetic counseling", "description": "The purpose of the webinar is to educate genetic counselors and other non-genetic healthcare providers about best practices for utilizing alternative service models to assist in the counseling of patients during the genetic pre-test phase.", "tags": ["US-78526"], "audience": ["hcp"], "tumorType": ["Pan"], "topic": [""], "language": ["english"], "publishedAt": "04-14-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor"], "surveyTestingChallenge": [] }, { "id": "US-78060", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/biomarker-testing-recommendations-advanced-prostate-cancer-hcp.png", "imageAlt": "Biomarker Testing Recommendations for Advanced Prostate Cancer for Healthcare Professionals", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/BiomarkerTestingRecommendationsForAdvancedProstateCancer.pdf", "size": "297.59 KB", "downloadSize": "297.59 KB" }, "website": {}, "label": "FOR HCPS", "title": "Biomarker testing recommendations for advanced prostate cancer", "description": "Review guideline-recommended testing for BReast CAncer susceptibility gene 1/2 (BRCA1/2) and other homologous recombination repair (HRR) gene mutations to help inform treatment decision-making.", "tags": ["US-78060"], "audience": ["hcp"], "tumorType": ["Prostate"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "02-27-2025", "speciality":["Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Prostate Tumor", "HRRm (BRCA1/2)"], "surveyTestingChallenge": [] }, { "id": "US-74638", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/biomarker-testing-medicare-billing-cms-policy.png", "imageAlt": "Biomarker Testing Guidance on Medicare Billing and CMS Laboratory Date of Service Policy", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/BiomarkerTestingMedicareBillingAndCMSLaboratoryDateofServicePolicy.pdf", "size": "1.41 MB", "downloadSize": "1.41 MB" }, "website": {}, "label": "FOR HCPS", "title": "Biomarker testing, medicare billing, and CMS laboratory date of service policy (the \"14-day rule\")", "description": "Download this policy update on the potential billing impact of the “14-day rule\" and what effects it may have on diagnostic testing for patients with cancer.", "tags": ["US-74638"], "audience": ["hcp"], "tumorType": ["Lung"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "02-23-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrB iomarker": [], "surveyTestingChallenge": [] }, { "id": "US-99342", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-90186.png", "imageAlt": "Detecting PIK3CA, AKT1, and PTEN alterations using next-generation sequencing (NGS)", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/CL1295995_PMM_Mini-deck_NCCN_Asset_Audit_v20.0.pdf", "size": "748 KB", "downloadSize": "748 KB" }, "website": {}, "label": "FOR HCPS", "title": "Detecting PIK3CA, AKT1, and PTEN alterations using next-generation sequencing (NGS)", "description": "Download this concise slide deck for an overview of the phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha (PIK3CA); serine/threonine protein kinase 1 (AKT1); phosphatase and tensin homolog (PTEN) pathway, NGS testing, and finding solutions to common testing challenges.", "tags": ["US-99342"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": ["testing-guidelines","testing-best-practices"], "language": ["english"], "publishedAt": "03-23-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor", "PIK3CA/AKT1/PTEN"], "surveyTestingChallenge": [] }, { "id": "US-72555", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72555.jpg", "imageAlt": "Gene mutations: Inherited vs acquired", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_aratihsa", "duration": "3:00 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_aratihsa/flavor/1_hmdjhcu2", "downloadSize": "57.1 MB", "fileName": "DxModularVideoGeneMutationsInheritedVersusAcquired.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Gene mutations: Inherited vs acquired", "description": "Understand the basics about the differences between inherited and acquired mutations, also known as germline and somatic mutations, in the cancer setting. Also includes a brief overview of why this testing may be recommended.", "tags": ["US-72555"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-13-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-72554", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72554.jpg", "imageAlt": "Genetic testing: How much does it really cost?", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_fubqr3im", "duration": "1:55 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_fubqr3im/flavor/1_7x8pqx32", "downloadSize": "33.4 MB", "fileName": "DxModularVideoTestingCost.mp4" }, "website": {}, "label": "FOR PATIENTS", "title": "Genetic testing: How much does it really cost?", "description": "Share this video with patients to give a brief overview of insurance coverage of genetic testing, including what information may be needed, and questions or considerations for patients and their healthcare team.", "tags": ["US-72554"], "audience": ["patient"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "03-26-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-37677", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-37677.jpg", "imageAlt": "Homologous recombination deficiency and cancer care", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_ths1faj5", "duration": "4:51 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_ths1faj5/flavor/1_lwbp0czz", "downloadSize": "109.8 MB", "fileName": "DiagnosticsHomologousRecombinationDeficiencyAndCancerCareVideo.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Homologous recombination deficiency and cancer care", "description": "Watch how homologous recombination deficiency (HRD) testing can help with tumor characterization and the development of a personalized treatment plan.", "tags": ["US-37677"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "02-12-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-72531", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72531.jpg", "imageAlt": "How does GINA protect you?", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_5l35foau", "duration": "2:18 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_5l35foau/flavor/1_69b2ga07", "downloadSize": "43.6 MB", "fileName": "DxModularvideoGINA.mp4" }, "website": {}, "label": "FOR PATIENTS", "title": "How does GINA protect you?", "description": "Share the Genetic Information Nondiscrimination Act (GINA) with your patients to highlight benefits and limitations of this law as it pertains to genetic testing.", "tags": ["US-72531"], "audience": ["patient"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "03-27-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-104124", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-71584.jpeg", "imageAlt": "HRD Testing Can Inform Clinical Decisions in Patients With Advanced Ovarian Cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/US-104124-ONC-Unbranded-Dx-HRD-Leave-Behind-2025-Update_AFD_digital.pdf", "size": "17.4 MB", "downloadSize": "17.4 MB" }, "website": {}, "label": "FOR HCPS", "title": "HRD Testing Can Inform Clinical Decisions in Patients With Advanced Ovarian Cancer", "description": "Learn how homologous recombination deficiency (HRD) testing, including markers of genomic instability, can impact treatment plans for advanced ovarian cancer and guideline recommendations for HRD testing.", "tags": ["US-104124"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-guidelines","testing-best-practices"], "language": ["english"], "publishedAt": "04-17-2025", "speciality":["MDT"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-72553", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72553.jpg", "imageAlt": "Informed consent for genetic testing: Before the test, learn what to expect", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_esqhtld1", "duration": "3:58 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_esqhtld1/flavor/1_cfmdjdcs", "downloadSize": "72.7 MB", "fileName": "DxModularvideoInformedConsentinGeneticTesting.mp4" }, "website": {}, "label": "FOR PATIENTS", "title": "Informed consent for genetic testing: Before the test, learn what to expect", "description": "Watch an overview of the informed consent process typically associated with genetic testing for cancer or hereditary cancer testing.", "tags": ["US-72553"], "audience": ["patient"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "02-14-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-72762", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72762.jpg", "imageAlt": "Leading the way: Approaches in biomarker testing for cancer treatment with Dana Clark", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_ih7ktzq9", "duration": "12:45 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_ih7ktzq9/flavor/1_ajqlfvbr", "downloadSize": "187.2 MB", "fileName": "LeadingTheWayDxTestingVideoWithDanaClark.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Approaches in biomarker testing for cancer treatment with Dana Clark", "description": "Watch Dana Clark, a genetic counselor, share her experience in standardizing biomarker testing in advanced ovarian cancer, involving pilot efforts, negotiating responsibilities, and implementing a user-friendly tracking system to improve biomarker testing rates.", "tags": ["US-72762"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "02-13-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-71412", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-71412.jpg", "imageAlt": "Leading the way: Approaches in biomarker testing for cancer treatment with Michelle Shiller", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_aibku5mu", "duration": "11:25 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_aibku5mu/flavor/1_nzzm4rx2", "downloadSize": "124.7 MB", "fileName": "DiagnosticTestingVideowithDrMichelleShiller.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Approaches in biomarker testing for cancer treatment with Michelle Shiller", "description": "Watch Dr Michelle Shiller share her experience leading in biomarker testing standardization in advanced ovarian cancer. She discusses her motives to improve testing rates, challenges, approaches, and the outcome of these efforts.", "tags": ["US-71412"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "02-19-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-73265", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-73265.jpg", "imageAlt": "Leading the way: Approaches in biomarker testing with Robert Neff, MD and Courtney Rice, LCGC", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_ev36rl8d", "duration": "12:45 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_ev36rl8d/flavor/1_247u0gco", "downloadSize": "116.4 MB", "fileName": "TrihealthLeadingTheWayDxTestingVideo.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Approaches in biomarker testing with Robert Neff, MD and Courtney Rice, LCGC", "description": "Watch Dr Robert Neff and Courtney Rice lead biomarker testing standardization strategies in advanced ovarian cancer at TriHealth, a Cincinnati based healthcare system.", "tags": ["US-73265"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "02-20-2025", "speciality":["MDT"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76516", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76516.jpg", "imageAlt": "Leading the way: Becoming a testing champion with Dr Michelle Shiller", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_z3uzt25e", "duration": "4:34 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_z3uzt25e/flavor/1_a96sx92u", "downloadSize": "105.4 MB", "fileName": "LeadingTheWayBecomingATestingChampionWithDrMichelleShiller.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Becoming a testing champion with Dr Michelle Shiller", "description": "This video series partners with Dr Michelle Shiller of Baylor Health. The chapterized video focuses on how diagnostic testing has been implemented at Baylor Health.", "tags": ["US-76516"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-02-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76525", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76525.jpg", "imageAlt": "Leading the way: Design a standard protocol with Dr Michelle Shiller", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_fmxlbx0i", "duration": "3:30 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_fmxlbx0i/flavor/1_iic2oahy", "downloadSize": "80 MB", "fileName": "LeadingtheWayDesignAStandardProtocolWithDrMichelleShiller.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Design a standard protocol with Dr Michelle Shiller", "description": " ", "tags": ["US-76525"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-04-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76541", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76541.jpg", "imageAlt": "Leading the way: Develop a strong relationship with IT with Ms Courtney Rice", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_y1wj3y22", "duration": "3:36 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_y1wj3y22/flavor/1_1dbp2ys3", "downloadSize": "131.2 MB", "fileName": "LeadingTheWayDevelopAStrongRelationshipWithITWithMsCourtneyRice.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Develop a strong relationship with IT with Ms Courtney Rice", "description": "This video series partners with Dr Robert Neff and Courtney Rice of Trihealth to develop a chapterized video focused on how diagnostic testing has been implemented at Trihealth.", "tags": ["US-76541"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-11-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76528", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76528.jpg", "imageAlt": "Leading the way: Employing user-friendly tracking systems with Ms Dana Clark", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_9wj9eyc7", "duration": "3:37 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_9wj9eyc7/flavor/1_9vxzc12w", "downloadSize": "164.3 MB", "fileName": "LeadingTheWayEmployingUserFriendlyTrackingSystemsWithMsDanaClark.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Employing user-friendly tracking systems with Ms Dana Clark", "description": "This video series partners with Dana Farengo Clark of UPENN to develop a chapterized video focused on how diagnostic testing has been implemented at UPENN.", "tags": ["US-76528"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-07-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76529", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76529.jpg", "imageAlt": "Leading the way: Form a dedicated precision oncology committee with Ms Courtney Rice", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_eejni4rs", "duration": "3:40 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_y1wj3y22/flavor/1_1dbp2ys3", "downloadSize": "133.8 MB", "fileName": "LeadingTheWayFormADedicatedPrecisionOncologyCommitteeWithMsCourtneyRice.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Form a dedicated precision oncology committee with Ms Courtney Rice", "description": "This video series partners with Dr Robert Neff and Courtney Rice of Trihealth to develop a chapterized video focused on how diagnostic testing has been implemented at Trihealth.", "tags": ["US-76529"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-08-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76535", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76535.jpg", "imageAlt": "Leading the way: Monitor testing orders with commercial labs with Dr Robert Neff", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_ejzht9xl", "duration": "2:45 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_ejzht9xl/flavor/1_ry4ocj1x", "downloadSize": "98.6 MB", "fileName": "LeadingtheWayMonitorTestingOrdersWithCommercialLabsWithDrRobertNeff.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Monitor testing orders with commercial labs with Dr Robert Neff", "description": "This video series partners with Dr Robert Neff and Courtney Rice of Trihealth to develop a chapterized video focused on how diagnostic testing has been implemented at Trihealth.", "tags": ["US-76535"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-10-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76523", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76523.jpg", "imageAlt": "Leading the way: Need to standardize biomarker testing with Dr Michelle Shiller", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_t8ngi04j", "duration": "3:31 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_t8ngi04j/flavor/1_jku821up", "downloadSize": "80.8 MB", "fileName": "LeadingTheWayNeedtoStandardizeBiomarkerTestingWithDrMichelleShiller.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Need to standardize biomarker testing with Dr Michelle Shiller", "description": "This video series partners with Dr Michelle Shiller of Baylor Health. The chapterized video focuses on how diagnostic testing has been implemented at Baylor Health.", "tags": ["US-76523"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-03-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76527", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76527.jpg", "imageAlt": "Leading the way: Negotiating responsibilities with Ms Dana Clark", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_z3avld0v", "duration": "4:07 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_z3avld0v/flavor/1_1dkxrhgg", "downloadSize": "159.2 MB", "fileName": "LeadingTheWayNegotiatingResponsibilitiesWithMsDanaClark.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Negotiating responsibilities with Ms Dana Clark", "description": " ", "tags": ["US-76527"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-06-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76532", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76532.jpg", "imageAlt": "Leading the way: Revamped workflows with Dr Robert Neff", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_lv315563", "duration": "4:52 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_lv315563/flavor/1_cl0al0ph", "downloadSize": "178.9 MB", "fileName": "LeadingTheWayRevampedWorkflowsWithDrRobertNeff.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Revamped workflows with Dr Robert Neff", "description": "This video series partners with Dr Robert Neff and Courtney Rice of Trihealth to develop a chapterized video focused on how diagnostic testing has been implemented at Trihealth.", "tags": ["US-76532"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-09-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-76526", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-76526.jpg", "imageAlt": "Leading the way: Starting with pilot efforts with Ms Dana Clark", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_6jm19ra4", "duration": "4:10 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_6jm19ra4/flavor/1_49f5xu70", "downloadSize": "175.3 MB", "fileName": "LeadingTheWayStartingWithPilotEffortsWithMsDanaClark.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Leading the way: Starting with pilot efforts with Ms Dana Clark", "description": "This video series partners with Dana Farengo Clark of UPENN to develop a chapterized video focused on how diagnostic testing has been implemented at UPENN.", "tags": ["US-76526"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": [""], "language": ["english"], "publishedAt": "04-05-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-79716", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-79716.jpeg", "imageAlt": "Lung Cancer Turnaround Time Tracker", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/LungCancerTurnaroundTimeTracker.xlsm", "size": "8.56 MB", "downloadSize": "8.56 MB" }, "website": {}, "label": "FOR HCPS", "title": "Lung Cancer Turnaround Time Tracker", "description": "A resource that care teams can use to track lung cancer testing turnaround times for each step in the process (lung cancer testing processes may vary by institution). A user guide explaining how to use the Lung Cancer Turnaround Time tracker is located in the Resource Library.", "tags": ["US-79716"], "audience": ["hcp"], "tumorType": ["Lung"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "04-16-2025", "speciality":["MDT"], "surveyTopic": ["Testing Solutions"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Sample Processing", "Reporting & Results Delivery"] }, { "id": "US-83485", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-83485.jpeg", "imageAlt": "Lung Cancer Turnaround Time Tracker User Guide", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/LungCancerTurnaroundTimeTrackerUserGuide.pdf", "size": "786.95 KB", "downloadSize": "786.95 KB" }, "website": {}, "label": "FOR HCPS", "title": "Lung Cancer Turnaround Time Tracker User Guide", "description": "The user guide explains how to use the Lung Cancer Turnaround Time Tracker. The Turnaround Time Tracker may be found in the Resource Library.", "tags": ["US-83485"], "audience": ["hcp"], "tumorType": ["Lung"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "04-15-2025", "speciality":["MDT"], "surveyTopic": ["Testing Solutions"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Sample Processing", "Reporting & Results Delivery"] }, { "id": "US-42494", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-42494.jpg", "imageAlt": "Optimizing biomarker testing for patients with metastatic prostate cancer", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_tcb9n3jr", "duration": "7:15 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_tcb9n3jr/flavor/1_f8ru0jhf", "downloadSize": "164.2 MB", "fileName": "OptimizingBiomarkerTestingForPatientsWithMetastaticProstateCancer.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Optimizing biomarker testing for patients with metastatic prostate cancer", "description": "Learn how biomarker testing for mutations in homologous recombination repair (HRR) genes, such as BReast CAncer susceptibility gene 1/2 (BRCA1/2) may be used to help guide treatment decisions.", "tags": ["US-42494"], "audience": ["hcp"], "tumorType": ["Prostate"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "02-21-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Prostate Tumor" , "HRRm (BRCA1/2)"], "surveyTestingChallenge": [] }, { "id": "US-75254", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-75254.jpg", "imageAlt": "Ovarian cancer connect: Evolution of testing in ovarian cancer (Episode 2)", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_77nhaxc9", "duration": "4:24 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_77nhaxc9/flavor/1_oupfmenr", "downloadSize": "162.6 MB", "fileName": "HDTestingEpisode2EvolutionOfTestingInOvarianCancerMp4Format.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Ovarian cancer connect: Evolution of testing in ovarian cancer (Episode 2)", "description": "Unbranded podcast series titled Ovarian Cancer Connect featuring 1-3 ESEs discussing Ovarian Cancer and Homologous Recombination Deficiency (HRD) testing in their practices.", "tags": ["US-75254"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": [""], "language": ["english"], "publishedAt": "03-29-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-75256", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-75256.jpg", "imageAlt": "Ovarian cancer connect: HRD what? HRD why? (Episode 3)", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_uqgpn5um", "duration": "4:19 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_uqgpn5um/flavor/1_usnormao", "downloadSize": "155.4 MB", "fileName": "TestingEpisode3HRDWhatHRDWhy.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Ovarian cancer connect: HRD what? HRD why? (Episode 3)", "description": "Unbranded podcast series titled Ovarian Cancer Connect featuring 1-3 ESEs discussing Ovarian Cancer and Homologous Recombination Deficiency (HRD) testing in their practices.", "tags": ["US-75256"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": [""], "language": ["english"], "publishedAt": "03-30-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-75259", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-75259.jpg", "imageAlt": "Ovarian cancer connect: To test or not to test - tips for how to implement a testing flow in your practice (Episode 4)", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_vps4o6gx", "duration": "5:26 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_vps4o6gx/flavor/1_9hnzkqdv", "downloadSize": "213.9 MB", "fileName": "HRDTestingEpisode4ToTestortoNotTestmp4Format.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Ovarian cancer connect: To test or not to test - tips for how to implement a testing flow in your practice (Episode 4)", "description": "Unbranded podcast series titled Ovarian Cancer Connect featuring 1-3 ESEs discussing Ovarian Cancer and homologous recombination deficiency (HRD) testing in their practices.", "tags": ["US-75259"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": [""], "language": ["english"], "publishedAt": "03-31-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-94676", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-88394.png", "imageAlt": "PIK3CA, AKT1, and PTEN biomarker testing in breast cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/US-94676-POPULATED-VERSION-FINAL-7-22-25-DIGITAL-SINGLE-PAGE.pdf", "size": "1.8 MB", "downloadSize": "1.8 MB" }, "website": {}, "label": "FOR HCPS", "title": "PIK3CA, AKT1, and PTEN biomarker testing in breast cancer", "description": "AKT1, serine/threonine protein kinase; PIK3CA, Phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha; PTEN, phosphatase and tensin homolog.
Download this guide on identifying all patients with mutation in hormone receptor (HR); human epidermal growth factor receptor 2 (HR+/HER2) - metastatic breast cancer advanced breast cancer using next-generation sequencing (NGS) panel tests.", "tags": ["US-94676"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "03-24-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor" , "PIK3CA/AKT1/PTEN"], "surveyTestingChallenge": [] }, { "id": "US-30240", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-30240.jpg", "imageAlt": "Role of BRCA1/2 mutations in breast cancer", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_su5z6h1h", "duration": "1:22 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_su5z6h1h/flavor/1_i9akl2j0", "downloadSize": "20.3 MB", "fileName": "DxBRCAInBCMODVideo.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Role of BRCA1/2 mutations in breast cancer", "description": "Learn how BReast CAncer susceptibility gene (BRCA) mutations may play a role in breast cancer development and understand the role of poly (ADP-ribose) polymerase (PARP).", "tags": ["US-30240"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": ["biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "03-15-2024", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor" , "BRCA1/2"], "surveyTestingChallenge": [] }, { "id": "US-80805", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-80805.png", "imageAlt": "Testing for germline BRCA mutations in metastatic BReast Cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/FINAL6302021Clean.pdf", "size": "954.65 KB", "downloadSize": "954.65 KB" }, "website": {}, "label": "FOR HCPS", "title": "Testing for germline BRCA mutations in metastatic BReast Cancer", "description": "Learn how germline BReast CAncer susceptibility gene (BRCA) mutation testing for all patients with recurrent or metastatic breast cancer can help inform treatment decisions.", "tags": ["US-80805"], "audience": ["hcp"], "tumorType": ["Lung"], "topic": ["testing-guidelines","testing-best-practices"], "language": ["english"], "publishedAt": "03-13-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor" , "BRCA1/2"], "surveyTestingChallenge": [] }, { "id": "US-77836", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-77836.png", "imageAlt": "Testing for homologous recombination repair mutations (HRRm), including BReast CAncer susceptibility gene 1/2 (BRCA1/2), can help guide treatment options in advanced prostate cancer.", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/FINAL41524.pdf", "size": "8.73 MB", "downloadSize": "8.73 MB" }, "website": {}, "label": "FOR HCPS", "title": "Testing for homologous recombination repair mutations (HRRm), including BReast CAncer susceptibility gene 1/2 (BRCA1/2), can help guide treatment options in advanced prostate cancer.", "description": "Use this interactive PDF as a comprehensive resource for detailed information on prostate cancer and genetic testing.", "tags": ["US-77836"], "audience": ["hcp"], "tumorType": ["Prostate"], "topic": ["testing-guidelines","testing-best-practices","biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "02-24-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Prostate Tumor" , "HRRm (BRCA1/2)"], "surveyTestingChallenge": [] }, { "id": "US-37392", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-37392.jpg", "imageAlt": "The role of molecular testing in advanced ovarian cancer", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_8meqkh10", "duration": "3:45 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_8meqkh10/flavor/1_yie1b0yb", "downloadSize": "158.1 MB", "fileName": "DDRVideoVignetteDrElNaggarAbbreviated.mp4" }, "website": {}, "label": "FOR HCPS", "title": "The role of molecular testing in advanced ovarian cancer", "description": "Watch Dr ElNaggar discuss the clinical utility of homologous recombination deficiency (HRD) and how testing for HRD at diagnosis can help identify appropriate treatment options in advanced ovarian cancer.", "tags": ["US-37392"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-best-practices","testing-best-practices"], "language": ["english"], "publishedAt": "02-10-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-72548", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-72548.jpg", "imageAlt": "What your genetic test means for your family members", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_mop7g4t4", "duration": "2:07 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_mop7g4t4/flavor/1_fhqik9tc", "downloadSize": "46 MB", "fileName": "DxModularVideoImplicationsforRelatives.mp4" }, "website": {}, "label": "FOR PATIENTS", "title": "What your genetic test means for your family members", "description": "Share this brief explanation with your patients on how germline (or inherited) genetic mutations can provide information to other family members if they choose to pursue genetic testing for hereditary cancer risk.", "tags": ["US-72548"], "audience": ["patient"], "tumorType": ["Pan-tumor"], "topic": ["biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "02-15-2025", "speciality":["MDT","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-75253", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-75253.jpg", "imageAlt": "Ovarian cancer connect: Introduction to this podcast series (Episode 1)", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_kw95n89v", "duration": "3:22 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_kw95n89v/flavor/1_bwdy90x1", "downloadSize": "123 MB", "fileName": "HRDTestingEpisode1IntroductiontoThisPodcastSeriesmp4Format.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Ovarian cancer connect: Introduction to this podcast series (Episode 1)", "description": "Unbranded podcast series titled Ovarian Cancer Connect featuring 1-3 ESEs discussing Ovarian Cancer and homologous recombination deficiency (HRD) testing in their practices.", "tags": ["US-75253"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": [""], "language": ["english"], "publishedAt": "03-28-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [] }, { "id": "US-80761", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-80761.jpg", "imageAlt": "Ovarian cancer connect: Talking with your patient about testing (Episode 5)", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_olkq6qqg", "duration": "4:58 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_olkq6qqg/flavor/1_hd6l314n", "downloadSize": "184 MB", "fileName": "TestingEpisode5TalkingWithYourPatientAboutTestingMp4Format.mp4" }, "website": {}, "label": "FOR HCPS", "title": "Ovarian cancer connect: Talking with your patient about testing (Episode 5)", "description": "Leading gynecologic oncologists Dr John Nakayama, Dr Joshua Kesterson, and Dr Alex Olawaiye discuss key considerations and approaches for talking to patients with advanced ovarian cancer about the importance of biomarker testing.", "tags": ["US-80761"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": [""], "language": ["english"], "publishedAt": "04-01-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "URL-APM", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/pathology-hcp-resource.webp", "imageAlt": "Association for Molecular Pathology (AMP) Educational Resource for HCPs", "website": { "url":"https://www.amp.org/" }, "label": "FOR HCPS", "title": "Association for Molecular Pathology (AMP)", "description": "", "tags": ["URL-APM"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "03-10-2025", "speciality":["Pathologist","Genetic Counselor"] }, { "id": "URL-BRCA", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/brca-awareness-patient-education-website.webp", "imageAlt": "BRCA Awareness Educational Website for Patients", "website": { "url":"https://www.bebrcaware.com/" }, "label": "FOR PATIENTS", "title": "Be BRCA-aware patient website", "description": "Share this website with your patients to help them understand how BReast CAncer susceptibility gene (BRCA) status can help them make the most out of their treatment.", "tags": ["URL-BRCA"], "audience": ["patient"], "tumorType": ["Pan-tumor"], "topic": ["biomarker-role-in-pathophysiology"], "language": ["english"], "publishedAt": "03-05-2025", "speciality":["MDT","Genetic Counselor"] }, { "id": "URL-CAP", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/pathology-hcp-resource.webp", "imageAlt": "College of American Pathologists Professional Resource for Healthcare Professionals", "website": { "url":"https://www.cap.org/" }, "label": "FOR HCPS", "title": "College of American Pathologists (CAP)", "description": "", "tags": ["URL-CAP"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines","interpreting-test-results"], "language": ["english"], "publishedAt": "03-08-2025", "speciality":["Pathologist"] }, { "id": "URL-DGS", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/resource-website-bg.webp", "imageAlt": "www.completeyourdiagnosis.com", "website": { "url":"https://www.completeyourdiagnosis.com/" }, "label": "FOR PATIENTS", "title": "www.completeyourdiagnosis.com", "description": "", "tags": ["URL-DGS"], "audience": ["patient"], "tumorType": ["Lung"], "topic": [""], "language": ["english"], "publishedAt": "03-12-2025", "speciality":["MDT","Genetic Counselor"] }, { "id": "URL-NCCN", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/resource-website-bg.webp", "imageAlt": "National Comprehensive Cancer Network® (NCCN®)", "website": { "url":"https://www.nccn.org/" }, "label": "FOR HCPS", "title": "National Comprehensive Cancer Network® (NCCN®)", "description": "", "tags": ["URL-NCCN"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "03-07-2025", "speciality":["MDT","Pathologist","Genetic Counselor"] }, { "id": "URL-NSGC", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/resource-website-bg.webp", "imageAlt": "National Society of Genetic Counselors (NSGC)", "website": { "url":"https://www.nsgc.org/" }, "label": "FOR HCPS", "title": "National Society of Genetic Counselors (NSGC)", "description": "", "tags": ["URL-NSGC"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "03-09-2025", "speciality":["Genetic Counselor"] }, { "id": "URL-TYL", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/resource-website-bg.webp", "imageAlt": "www.treatyourlungcancer.com", "website": { "url":"https://www.treatyourlungcancer.com/" }, "label": "FOR PATIENTS", "title": "www.treatyourlungcancer.com", "description": "", "tags": ["URL-TYL"], "audience": ["patient"], "tumorType": ["Lung"], "topic": [""], "language": ["english"], "publishedAt": "03-04-2025", "speciality":["MDT"] }, { "id": "US-100664", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/desktop/esr1/US-103623.png", "imageAlt": "ctDNA-mediated testing for ESR1 mutations in patients with advanced breast cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/US-100664_ONC_UNBRANDED_ESR1_Dx_Mini_Deck.pdf", "size": "1.79 MB", "downloadSize": "1.79 MB" }, "website": {}, "label": "FOR PATIENTS", "title": "ctDNA-mediated testing for ESR1 mutations in patients with advanced breast cancer", "description": "Download this mini deck to elevate your awareness of the prevalence of estrogen receptor gene 1 (ESR1) mutations and the impact of predictive circulating tumor DNA (ctDNA)-mediated noninvasive testing in hormone receptor (HR); human epidermal growth factor receptor 2 (HR+/HER2-) advanced breast cancer.", "tags": ["US-100664"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": [""], "language": ["english"], "publishedAt": "11-10-2025", "speciality":["MDT","Pathologist"], "surveyTopic": ["Precision Medicine Trends & Advancements"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-97272", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/hrd-testing-guide-that-provides-background-on-hrd-biomarkers.jpg", "imageAlt": "HRD Testing Guide that Provides Background on HRD Biomarkers", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/homologous-recombination-deficiency-testing-in-patients-with-advanced-ovarian-cancer.pdf", "size": "20.7 MB", "downloadSize": "20.7 MB" }, "website": {}, "label": "FOR HCPS", "title": "Homologous recombination deficiency testing in patients with Advanced ovarian cancer", "description": "An interactive guide to Homologous Recombination Deficiency (HRD) testing that provides background on HRD biomarkers and highlights the importance of testing. The guide will help the multidisciplinary team determine who, what, when, and how to test patients with advanced ovarian cancer.", "tags": ["US-97272"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology","testing-best-practices","interpreting-test-results"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Ovarian Tumor" , "HRD"], "surveyTestingChallenge": [""] }, { "id": "US-94325", "type": "video", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/the-breast-guide-video-thumbnail.jpg", "imageAlt": "Video on How Biomarker Testing Guides Breast Cancer Treatment by Breast surgeon Dr. Monique Gary", "video": { "kalturaId": "", "kalturaIframe": "https://cdnapisec.kaltura.com/p/432521/embedPlaykitJs/uiconf_id/53695392?iframeembed=true&entry_id=1_4o9v4okh", "duration": "19:00 MIN", "downloadUrl": "https://www.kaltura.com/p/432521/sp/43252100/download/entry_id/1_4o9v4okh/flavor/1_tihef7k4", "downloadSize": "665 MB", "fileName": "the-breast-guest-episode-1-understanding-genetic-counseling.mp4" }, "website": {}, "label": "FOR HCPS", "title": "The Breast Guest Episode 1: Understanding Genetic Counseling", "description": "Genetic counselor Brian Reys explains the critical role of genetic counselors in the genetic testing process for oncology patients.", "tags": ["US-94325"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": ["testing-guidelines","testing-best-practices","interpreting-test-results"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Precision Medicine Benefits"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Watch or listen", "No preference"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "US-98429", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-98429.jpg", "imageAlt": "HER2 Can Be Here, Too: Pathology Guide", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/her2-can-be-here-too-pathology-guide.pdf", "size": "8.57 MB", "downloadSize": "8.57 MB" }, "website": {}, "label": "FOR HCPS", "title": "HER2 Can Be Here, Too: Pathology Guide", "description": "Expand your human epidermal growth factor receptor 2 (HER2) testing expertise beyond breast cancer with 'HER2 Can Be Here, Too.' This digital brochure helps pathologists understand the clinical relevance of HER2 immunohistochemistry (IHC) testing across multiple solid tumor types and provides essential testing recommendations and reporting tools.", "tags": ["US-98429"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology","testing-best-practices","interpreting-test-results"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Lung Tumor" , "HER2" , "ERBB2 (HER2)"], "surveyTestingChallenge": [""] }, { "id": "US-103474", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-103474.jpg", "imageAlt": "mNSCLC HER2 testing: Pathology guide", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/mnsclc-her2-testing-pathology-guide.pdf", "size": "731 KB", "downloadSize": "731 KB" }, "website": {}, "label": "FOR HCPS", "title": "mNSCLC HER2 testing: Pathology guide", "description": "Master human epidermal growth factor receptor 2 (HER2) testing for metastatic non-small cell lung cancer (mNSCLC) patients. This downloadable guide provides pathologists with key testing guidelines and best practices covering both HER2 immunohistochemistry (IHC) for protein overexpression and next-generation sequencing (NGS) for HER2 (ERBB2) mutations.", "tags": ["US-103474"], "audience": ["hcp"], "tumorType": ["Lung"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology","testing-best-practices","interpreting-test-results"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Lung Tumor" , "ERBB2 (HER2)"], "surveyTestingChallenge": [""] }, { "id": "US-104111", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/US-104111.jpg", "imageAlt": "HRD and HER2 IHC testing for advanced ovarian cancer: MDT guide", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/HRD-and-HER2-IHC-testing-for-advanced-ovarian-cancer-MDT-guide.pdf", "size": "3MB", "downloadSize": "3MB" }, "website": {}, "label": "FOR HCPS", "title": "HRD and HER2 IHC testing for advanced ovarian cancer: MDT guide", "description": "Are you ordering both homologous recombination deficiency (HRD) and human epidermal growth factor receptor 2 immunohistochemistry (HER2) immunohistochemistry (IHC) testing for your advanced ovarian cancer patients? This introductory resource gives provides the essential starting points plus a non-exhaustive list of labs conducting both tests.", "tags": ["US-104111"], "audience": ["hcp"], "tumorType": ["Ovarian"], "topic": ["testing-best-practices"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Testing Solutions"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": [""], "surveyTestingChallenge": ["Test Ordering"] }, { "id": "URL-H2K", "type": "website", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/assets/thumbnail/her2know.jpg", "imageAlt": "HER2Know", "website": { "url":"https://www.her2know.com/" }, "label": "FOR HCPS", "title": "HER2Know.com", "description": "HER2Know.com is a by pathologists, for pathologists educational hub. Access comprehensive resources for human epidermal growth factor receptor 2 (HER2) testing in breast, lung, gynecologic tumors and beyond, plus an extensive gallery of whole slide images.", "tags": ["URL-H2K"], "audience": ["hcp"], "tumorType": ["Pan-tumor"], "topic": ["testing-guidelines"], "language": ["english"], "publishedAt": "03-10-2025", "surveyTopic": ["Biomarker Testing Guidelines"], "surveyTumorOrBiomarker": ["Lung Tumor" , "HER2" , "ERBB2 (HER2)"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "speciality":["MDT","Pathologist","Genetic Counselor"] }, { "id": "US-103455", "type": "pdf", "imageUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/images/resource-library-update/json-assets/esr1-mutations-detection-metastatic-breast-cancer-hcp.jpg", "imageAlt": "Educational Resource on Detecting Emergent ESR1 Mutations in Metastatic Breast Cancer", "pdf": { "downloadUrl": "/content/dam/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/resource_assets/pdf/be-an-advocate-or-detection-of-emergent-esr1-mutations.pdf", "size": "1.19 MB", "downloadSize": "1.19 MB" }, "website": {}, "label": "FOR HCPS", "title": "Be an advocate for detection of emergent ESR1 mutations in HR+/HER2− mBC to identify acquired endocrine therapy resistance", "description": "This Leave Behind highlights the clinical value of detecting emergent estrogen receptor gene 1 (ESR1) mutation in hormone receptor (HR); human epidermal growth factor receptor 2 (HR+/HER2-) metastatic breast cancer. This guide features the what, why, whom, how, and where of ESR1 testing for oncologists.", "tags": ["US-103455"], "audience": ["hcp"], "tumorType": ["Breast"], "topic": ["testing-guidelines","biomarker-role-in-pathophysiology","testing-best-practices","interpreting-test-results"], "language": ["english"], "publishedAt": "12-22-2025", "speciality":["MDT","Pathologist","Genetic Counselor"], "surveyTopic": ["Biomarker Testing Guidelines"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["Read", "No preference"], "surveyTumorOrBiomarker": ["Breast Tumor"], "surveyTestingChallenge": [""] }, { "id": "WP-1", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/realizing-the-potential-of-precision-medicine.html" }, "title": "Realizing The Potential Of Precision Medicine", "description": "Collaborate across the MDT to address health inequity in biomarker testing and precision medicine.", "surveyTopic": ["Precision Medicine Benefits"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-2", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/realizing-the-potential-of-precision-medicine.html/#considerations" }, "title": "Realizing The Potential Of Precision Medicine", "description": "Collaborate across the MDT to address health inequity in biomarker testing and precision medicine.", "surveyTopic": ["Precision Medicine Benefits"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-3", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/latest-developments-in-precision-medicine.html" }, "title": "Latest Developments In Precision Medicine", "description": "Explore recent advances—from diagnostic technologies to novel biomarkers aiming to transform precision medicine.", "surveyTopic": ["Precision Medicine Trends & Advancements"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-4", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/latest-developments-in-precision-medicine.html#considerations" }, "title": "Latest Developments In Precision Medicine", "description": "Explore recent advances—from diagnostic technologies to novel biomarkers aiming to transform precision medicine.", "surveyTopic": ["Precision Medicine Trends & Advancements"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-5", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/find-a-testing-lab.html" }, "title": "Find a Testing Lab", "description": "Search our directory of major laboratories that perform diagnostic biomarker testing.", "surveyTopic": ["Testing Lab Directory"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-6", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/connect-with-us.html" }, "title": "Connect with us", "description": "Contact a Precision Medicine expert for answers to your biomarker testing questions.", "surveyTopic": ["Answers to My Biomarker Testing Questions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": [] }, { "id": "WP-7", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer.html" }, "title": "Lung Cancer | Precision Medicine", "description": "Discover guideline-recommended actionable and emerging biomarkers in NSCLC.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Lung Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-8", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer.html#considerations" }, "title": "Lung Cancer | Precision Medicine", "description": "Discover guideline-recommended actionable and emerging biomarkers in NSCLC.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Lung Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-9", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer/egfr-mutations.html" }, "title": "EGFR Mutations in NSCLC", "description": "Testing for EGFR mutations may help inform eligibility for targeted treatment in patients with NSCLC.1", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["EGFR"], "surveyTestingChallenge": [] }, { "id": "WP-10", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer/egfr-mutations.html#considerations" }, "title": "EGFR Mutations in NSCLC", "description": "Testing for EGFR mutations may help inform eligibility for targeted treatment in patients with NSCLC.1", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["EGFR"], "surveyTestingChallenge": [] }, { "id": "WP-11", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer/erbb2-her2-mutations.html" }, "title": "ERBB2 HER2 Mutations", "description": "Testing for ERBB2 (HER2) mutations may contribute to improved health outcomes of patients with NSCLC by informing eligibility for targeted treatment options.1", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["ERBB2 (HER2)"], "surveyTestingChallenge": [] }, { "id": "WP-12", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/lung-cancer/erbb2-her2-mutations.html#considerations" }, "title": "ERBB2 HER2 Mutations", "description": "Testing for ERBB2 (HER2) mutations may contribute to improved health outcomes of patients with NSCLC by informing eligibility for targeted treatment options.1", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["ERBB2 (HER2)"], "surveyTestingChallenge": [] }, { "id": "WP-13", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer.html" }, "title": "Precision Medicine for Breast Cancer", "description": "Discover guideline-recommended actionable and emerging biomarkers in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Breast Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-14", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer.html#considerations" }, "title": "Precision Medicine for Breast Cancer", "description": "Discover guideline-recommended actionable and emerging biomarkers in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Breast Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-15", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/brca-mutations.html" }, "title": "BRCA1/2 Mutations in Breast Cancer", "description": "Explore BRCA1/2 mutation testing in breast cancer with guideline recommendations and actionable best practices.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["BRCA1/2"], "surveyTestingChallenge": [] }, { "id": "WP-16", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/brca-mutations.html#considerations" }, "title": "BRCA1/2 Mutations in Breast Cancer", "description": "Explore BRCA1/2 mutation testing in breast cancer with guideline recommendations and actionable best practices.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["BRCA1/2"], "surveyTestingChallenge": [] }, { "id": "WP-17", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/her2-testing.html" }, "title": "HER2 Testing", "description": "Explore guideline recommendations and actionable best practices for HER2 IHC testing in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HER2"], "surveyTestingChallenge": [] }, { "id": "WP-18", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/her2-testing.html#considerations" }, "title": "HER2 Testing", "description": "Explore guideline recommendations and actionable best practices for HER2 IHC testing in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HER2"], "surveyTestingChallenge": [] }, { "id": "WP-19", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/pik3ca-akt1-pten-mutations.html" }, "title": "PIK3CA, AKT1, and PTEN Alterations in Breast Cancer", "description": "Explore guideline recommendations and actionable best practices for PIK3CA, AKT1, and PTEN testing in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["PIK3CA/AKT1/PTEN"], "surveyTestingChallenge": [] }, { "id": "WP-20", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/breast-cancer/pik3ca-akt1-pten-mutations.html#considerations" }, "title": "PIK3CA, AKT1, and PTEN Alterations in Breast Cancer", "description": "Explore guideline recommendations and actionable best practices for PIK3CA, AKT1, and PTEN testing in breast cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["PIK3CA/AKT1/PTEN"], "surveyTestingChallenge": [] }, { "id": "WP-21", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/ovarian-cancer.html" }, "title": "Precision Medicine for Ovarian Cancer", "description": "Discover guideline-recommended actionable biomarkers in ovarian cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Ovarian Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-22", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/ovarian-cancer.html#considerations" }, "title": "Precision Medicine for Ovarian Cancer", "description": "Discover guideline-recommended actionable biomarkers in ovarian cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Ovarian Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-23", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/ovarian-cancer/hrd-testing.html" }, "title": "HRD in Advanced Ovarian Cancer", "description": "Ensure eligible patients with ovarian cancer are tested for HRD.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HRD"], "surveyTestingChallenge": [] }, { "id": "WP-24", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/ovarian-cancer/hrd-testing.html#considerations" }, "title": "HRD in Advanced Ovarian Cancer", "description": "Ensure eligible patients with ovarian cancer are tested for HRD.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HRD"], "surveyTestingChallenge": [] }, { "id": "WP-25", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/prostate-cancer.html" }, "title": "Precision Medicine for Prostate Cancer", "description": "Discover guideline-recommended actionable and emerging biomarkers in prostate cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Prostate Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-26", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/prostate-cancer.html#considerations" }, "title": "Precision Medicine for Prostate Cancer", "description": "Discover guideline-recommended actionable and emerging biomarkers in prostate cancer.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["Prostate Tumor"], "surveyTestingChallenge": [] }, { "id": "WP-27", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/prostate-cancer/hrr-mutations.html" }, "title": "HRR Mutations, Including BRCA1/2 in Prostate Cancer", "description": "Optimize HRRm testing in prostate cancer with guideline recommendations and actionable best practices.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HRRm (BRCA1/2)"], "surveyTestingChallenge": [] }, { "id": "WP-28", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/prostate-cancer/hrr-mutations.html#considerations" }, "title": "HRR Mutations, including BRCA1/2 in Prostate Cancer", "description": "Optimize HRRm testing in prostate cancer with guideline recommendations and actionable best practices.", "surveyTopic": ["Biomarker Testing Guidelines"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": ["HRRm (BRCA1/2)"], "surveyTestingChallenge": [] }, { "id": "WP-29", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#sample-collection" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Sample Collection"] }, { "id": "WP-30", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#sample-processing" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Sample Processing"] }, { "id": "WP-31", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#diagnosis-staging" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Diagnosis & Staging"] }, { "id": "WP-32", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#test-ordering" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Test Ordering"] }, { "id": "WP-33", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#testing-interpretation" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Testing & Interpretation"] }, { "id": "WP-34", "type": "internal website", "website": { "url":"/content/intelligentcontent/unbranded/ic-precisionmed-hcp/us/en/home/testing-solutions.html#reporting-results-delivery" }, "title": "Testing Solutions", "description": "Overcome common biomarker testing challenges with actionable solutions.", "surveyTopic": ["Testing solutions"], "speciality": ["MDT", "Pathologist", "Genetic Counselor"], "surveyContentLength": ["5 or less minutes", "More than 5 minutes"], "surveyLearningPreference": ["No Preference", "Read", "Watch or listen"], "surveyTumorOrBiomarker": [], "surveyTestingChallenge": ["Reporting & Results Delivery"] } ]